| Date Filed | Type | Description |
| 10/01/2021 |
8-K
| Quarterly results |
| 08/13/2021 |
10-Q
| Quarterly Report for the period ended June 30, 2021 |
| 08/13/2021 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 07/16/2021 |
8-K
| Quarterly results |
| 07/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/07/2021 |
SC 13G
| ALPHA CAPITAL ANSTALT reports a 5.5% stake in SYNAPTOGENIX, INC. |
| 07/07/2021 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 07/07/2021 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 07/02/2021 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
| 06/29/2021 |
D
| Form D - Notice of Exempt Offering of Securities: |
| 06/25/2021 |
SC 13G
| INTRACOASTAL CAPITAL, LLC reports a 10% stake in Synaptogenix, Inc. |
| 06/24/2021 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
| 06/21/2021 |
8-K
| Other Events |
| 06/17/2021 |
3/A
| SCHECHTER JONATHAN (Director) has filed a Form 3/A on Synaptogenix, Inc. |
| 06/16/2021 |
8-K
| Quarterly results |
| 06/16/2021 |
4
| Alkon Daniel L. (Chief Scientific Officer) has filed a Form 4 on Synaptogenix, Inc.|
Txns:
| Bought 10,000 shares
@ $8.26, valued at
$82.6k
|
|
| 06/16/2021 |
4
| Silverman Joshua (Director) has filed a Form 4 on Synaptogenix, Inc.|
Txns:
| Bought 10,000 shares
@ $8.3, valued at
$83k
|
|
| 06/14/2021 |
3
| Singer William S. (Director) has filed a Form 3 on Synaptogenix, Inc. |
| 06/14/2021 |
3
| WEINSTEIN ROBERT (CFO) has filed a Form 3 on Synaptogenix, Inc. |
| 06/14/2021 |
3
| Silverman Joshua (Director) has filed a Form 3 on Synaptogenix, Inc. |
| 06/14/2021 |
3
| SCHECHTER JONATHAN (Director) has filed a Form 3 on Synaptogenix, Inc. |
| 06/14/2021 |
3
| Perry George (Director) has filed a Form 3 on Synaptogenix, Inc. |
| 06/14/2021 |
3
| Alkon Daniel L. (Chief Scientific Officer) has filed a Form 3 on Synaptogenix, Inc. |
| 06/14/2021 |
3
| Bernstein Bruce (Director) has filed a Form 3 on Synaptogenix, Inc. |
| 06/14/2021 |
3
| TUCHMAN ALAN J (CEO) has filed a Form 3 on Synaptogenix, Inc. |
| 06/04/2021 |
8-A12B
| Form 8-A12B - Registration of securities [Section 12(b)]: |
| 05/14/2021 |
10-Q
| Quarterly Report for the period ended March 31, 2021 |
|